Instructions For Use Caregivers

Skip to content

Evidence
Blog
Our Mission
FAQs
Contact Us
Download on the playstore
Download on the appstore

Evidence
Blog
Our Mission
FAQs
Contact Us
Download on the playstore
Download on the appstore

Navigating Adult ADHD and Finding Focus

gender differences

What is ADHD Masking and How Can it Impact ADHD Diagnoses in Women?
ADHD in Older Women | 5 Ways Aging Can Intersect with ADHD
ADHD Insider: This or That? A Not-So-Fun Game to Play When Treating ADHD with Stimulant Medication
ADHD in Women
4 Ways that ADHD Symptoms can Differ for Women
Is ADHD Different for Men and Women?
Debunking ADHD Stereotypes: It’s Not Just a Boy Thing

EndeavorOTC

FAQs
Contact
Instructions for Use
Privacy Notice
Health Data Policy

About Us

Akili Interactive
EndeavorRx
HCP EndeavorRx

Terms of Use

Terms of Use for Sites
Terms of Use for Apps

Receive the latest news, tips, and offers from EndeavorOTC.

By submitting this form, you consent to Akili sending marketing communications about our products and services.

¹ Stamatis, C. A., Mercaldi, C., & Kollins, S. H. (2023). A Single-Arm Pivotal Trial to Assess the Efficacy of Akl-T01, a Novel Digital Intervention for Attention, in Adults Diagnosed With ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 62(10), S318.
² As measured by improvement on the Test of Variable of Attention (TOVA^®) Attention Composite Score. The TOVA measures attention and other functions that assess the ability to focus.
³ As measured by the validated Adult ADHD Quality of Life Scale (AAQoL).

EndeavorOTC is a digital therapeutic indicated to improve attention function, ADHD symptoms, and quality of life in adults 18 years of age and older with primarily inattentive or combined-type ADHD. Please see the Instructions for Use for additional indication and safety information.

EndeavorOTC is made available under the U.S. Food and Drug Administration’s current Enforcement Policy for Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. EndeavorOTC has not been cleared or authorized by the U.S. Food and Drug Administration for any indications.

© 2024 Akili Interactive Labs, Inc. All Rights Reserved. Akili, EndeavorRx, Endeavor, Akili Care, ADHD Insight, Insight, EndeavorRx Insight, EndeavorOTC, SSME, and Akili Assist, as well as the logos for each, are trademarks or registered trademarks of Akili Interactive Labs, Inc. Other trademarks are trademarks or registered trademarks of their respective owners.

Sit tight, a representative from
Akili Assist^® will reach out to you soon.

In the meantime, learn more about EndeavorOTC by browsing our FAQ Page

×

How do I find my version number?

You can find your version number by tapping the "Product Label" from the Menu and looking at the "Release X.X.X" field in the EndeavorOTC app.